Company intelligence / Profile preview

ImprimisRx

Carlsbad, California, United Statesimprimisrx.com ↗

Ownership: Private
Employees: ~123
Development stage: Other

Overview

ImprimisRx commercializes proprietary and novel sterile and topical drug formulations for ophthalmology and other specialties. The company operates both FDA Registered Outsourcing Facilities (503B) for office use and traditional compounding pharmacies (503A) for patient-specific prescriptions. No clinical trial results are published as the business focuses on compounded medications rather than new molecular entities or FDA-approved drugs.

Therapeutic areas: OphthalmologyOther
Modalities: Small molecule (compounded formulations)Biologic (sterile injectables)Device (ophthalmic delivery devices; inferred from ophthalmic focus)
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on ImprimisRx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ImprimisRx.

Explore the full profile